Associations of A-FABP with Anthropometric and Metabolic Indices and Inflammatory Cytokines in Obese Patients with Newly Diagnosed Type 2 Diabetes

Table 1

Baseline clinical characteristics of subjects in different groups.

Group	Subjects	Male/female	Age	BMI (kg/m^2)	WHR
Normal control	30	16/14	50 ± 4.8	22.42 ± 1.3	0.81 ± 0.03
Simple obesity	30	14/16	49 ± 7.6	28.76 ± 1.8^☆	0.87 ± 0.06^☆
Type 2 diabetes
Nonobese	48	23/25	49 ± 5.6	23.04 ± 1.2^○	0.82 ± 0.04^○
Obese	42	22/20	50 ± 7.8	29.11 ± 1.6^☆∆	0.88 ± 0.05^☆∆

Data are mean ± SD or median. BMI: body mass index; WHR: waist hip rate. ^☆ < 0.05 versus normal control; ^○ < 0.05 versus simple obese group; ^∆ < 0.05 versus nonobese diabetic group.